Luspatercept for CIA in AML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Luspatercept for CIA in AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2026-06-23		NCT07663864

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Guangdong Medical University	27
First Affiliated Hospital of Guangxi Medical University	96
Guangdong Second Provincial General Hospital	22
Guangzhou 8th People's Hospital	11
Guangzhou First People's Hospital	32
Nanfang Hospital, Southern Medical University	248
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Hematology, Guangdong Second Provincial General Hospital	Guangzhou	China	4